Back to Results

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

Interested in this Trial?

Contact Us

Trial Status Recruiting

Trial Identifier

NCT06212947

Condition

Hypochondroplasia

The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.

Trial Summary

This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.

Eligibility Criteria

Birth Sex

All

Age

Up to 15 Years

Healthy Volunteers

No

Study Type:

Observational

Number of Participants:

400

Study Started:

2023-11-27

Study Updated:

2024-09-19

Trial Locations

  • Phoenix Children's Hospital

    Phoenix, Arizona, United States

  • Cedars-Sinai Medical Center

    Los Angeles, California, United States

  • UCSF Benioff Children's Hospital

    Oakland, California, United States

  • Nemours Alfred I. Dupont Hospital for Children

    Wilmington, Delaware, United States

  • Children's National Health System

    Washington, District of Columbia, United States

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois, United States

  • The Johns Hopkins University School of Medicine

    Baltimore, Maryland, United States

  • Boston Children's Hospital

    Boston, Massachusetts, United States

  • University of Minnesota Masonic Children's Hospital

    Minneapolis, Minnesota, United States

  • University of Missouri

    Columbia, Missouri, United States

  • Washington University School of Medicine in St. Louis

    Saint Louis, Missouri, United States

  • Mount Sinai Kravis Children's Hospital

    New York, New York, United States

  • Akron Children's Hospital

    Akron, Ohio, United States

  • Nationwide Children's Hospital

    Columbus, Ohio, United States

  • Cook Children's Endocrinology

    Fort Worth, Texas, United States

  • Medical College of Wisconsin, Children's Hospital

    Milwaukee, Wisconsin, United States

  • Hospital de Pediatria SAMIC Prof. Dr. Juan P Garrahan

    Buenos Aires, , Argentina

  • Royal Children's Hospital Melbourne

    Parkville, Victoria, Australia

  • Hospital de Clinicas de Porto Algre

    Porto Alegre, Rio Grande Do Sol, Brazil

  • Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto

    Ribeirão Preto, Sao Paulo, Brazil

  • Stollery Children's Hospital

    Edmonton, Alberta, Canada

  • SickKids - The Hospital for Sick Children

    Toronto, Ontario, Canada

  • Centre Hospitalier Universitaire Sainte-Justine

    Montréal, Quebec, Canada

  • Hospices Civils de Lyon - Hôpital Femme Mère Enfant

    Lyon, , France

  • Hopital de la Timone

    Marseille, , France

  • Hôpital Necker-Enfants Malades

    Paris, , France

  • CHU de Toulouse - Hopital des Efants

    Toulouse, , France

  • Uniklinik Koln

    Köln, , Germany

  • Universitatskinderklinik Magdeburg

    Magdeburg, , Germany

  • Istituto Giannina Gaslini

    Genoa, Liguria, Italy

  • Ospedale Pediatrico Bambino Gesù

    Roma, Rome, Italy

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan, , Italy

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Rome, , Italy

  • Osaka University Hospital

    Suita, Osaka, Japan

  • Tottori University Hospital

    Yonago, Tottori, Japan

  • Kumamoto University Hospital

    Kumamoto, , Japan

  • Tokushima University Hospital

    Tokushima, , Japan

  • Tokyo Medical and Dental University Hospital

    Tokyo, , Japan

  • Hospital Universitario La Paz

    Madrid, , Spain

  • Vithas Hospital San Jose

    Vitoria, , Spain

  • Great Ormond Street Hospital for Children NHS Foundation Trust

    London, England, United Kingdom

  • Myriad Trials Ltd

    London, England, United Kingdom

  • NHS Greater Glasgow and Clyde

    Glasgow, Scottland, United Kingdom

Inclusion Criteria

  • Participants must be ≤ 15 years old at the time of signing the informed consent
  • Participants must have genetic confirmation of Hypochondroplasia diagnosis

Exclusion Criteria

  • Have a diagnosis of another genetic short stature condition other than Hypochondroplasia or a genetic variant known to cause another genetic syndrome associated with short stature
  • Received an investigational product or medical device within 6 months before the Screening visi

Contact BioMarin Clinical Trials

Please complete and submit the following form to express interest in participating and request more information about one of our clinical trials.

By completing this form and clicking the send button, you understand and hereby consent to storage of your personal information, including within the United States and Europe, which will be accessible by BioMarin for purposes such as responding to your request, quality control, fulfilling compliance obligations, and assisting with products, services, or clinical trials. Depending on where you live, you may have the right to request access to, removal, or correction of your personal information held by BioMarin. You may submit your request via the contact information and/or webform located within the full BioMarin Privacy Policy.

*required fields

"*" indicates required fields

This field is hidden when viewing the form
This field is hidden when viewing the form

What’s Next?

Visit the following links to learn more about clinical trials.

Discuss this trial with your care team.

You may wish to print this page to share the details with your healthcare providers and discuss whether you may be eligible.

Print

Get in touch.

Contact Us